Tudor Investment Corp Et Al Purchases Shares of 9,062 Signify Health, Inc. (NYSE:SGFY)

Tudor Investment Corp Et Al purchased a new stake in Signify Health, Inc. (NYSE:SGFY – Get Rating) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 9,062 shares of the company’s stock, valued at approximately $264,000.

Several other institutional investors have also modified their holdings of the company. Glazer Capital LLC purchased a new stake in shares of Signify Health during the 3rd quarter worth $837,000. Renaissance Technologies LLC raised its stake in Signify Health by 1,466.9% during the 3rd quarter. Renaissance Technologies LLC now owns 274,200 shares of the company’s stock worth $7,993,000 after acquiring an additional 256,700 shares in the last quarter. Verition Fund Management LLC acquired a new stake in Signify Health during the 3rd quarter worth $2,403,000. Boothbay Fund Management LLC raised its stake in Signify Health by 48.6% during the 3rd quarter. Boothbay Fund Management LLC now owns 117,423 shares of the company’s stock worth $3,423,000 after acquiring an additional 38,413 shares in the last quarter. Finally, Ergoteles LLC raised its stake in Signify Health by 156.2% during the 3rd quarter. Ergoteles LLC now owns 226,438 shares of the company’s stock worth $6,601,000 after acquiring an additional 138,058 shares in the last quarter. 89.99% of the stock is owned by hedge funds and other institutional investors.

Signify Health Trading Up 0.7 %

Shares of Signify Health stock opened at $28.49 on Friday. Signify Health, Inc. has a 52-week low of $10.70 and a 52-week high of $29.88. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.41. The company’s 50-day simple moving average is $28.67 and its 200-day simple moving average is $28.78. The firm has a market cap of $6.74 billion, a price-to-earnings ratio of -8.66 and a beta of 0.37.

Analyst Ratings Changes

Separately, TheStreet lowered shares of Signify Health from a “c-” rating to a “d” rating in a research note on Monday, February 13th. Nine equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $28.15.

Signify Health Profile

(Get Rating)

Signify Health, Inc operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates through Home & Community Services and Episodes of Care Services segments. The Home & Community Services segment offers health evaluations performed within the patient's home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health.